Labsystems Diagnostics has been a pioneer in diagnostic development for 30 years. The company develops, manufactures and markets high quality enzyme immunoassays (EIA and FEIA) and rapid Point of Care (POC) tests globally for clinical laboratory use, home use and doctors offices.
As a result of the new distribution agreement, Oxford Biosystems will represent Labsystems Diagnostics in the UK and the Republic of Ireland. The Labsystems products for infectious diseases and gastrointestinal disorders will complement the existing Oxford Biosystems product range extremely well. As a pioneer in Newborn Screening (NBS) Labsystems have a range of high quality products and instrumentation that we are looking forward to introducing to our customers.